Skip to search formSkip to main contentSkip to account menu

CMV pp65 peptide

Known as: CMV N495 Peptide, CMV-PEP 
A peptide derived from cytomegalovirus (CMV) internal matrix protein pp65. CMV pp65 peptide antigen is used in recombinant vaccinia virus as an HLA-A… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
CONTEXT - Cytomegalovirus (CMV) can be transmitted by cellular blood products, leading to severe disease in immunosuppressed… 
2012
2012
In the present study, we constructed a lentivirus, FIV-CMV-GFP-miR-7-3, containing the microRNA-7-3 gene and the green… 
2005
2005
Foscarnet is currently licensed for the treatment of human cytomegalovirus (HCMV) infection. Mutations proven to confer… 
2004
2004
OBJECTIVE Cytomegalovirus (CMV) infection was greatly common in the world. CMV infection produces usually mild or asymptomatic… 
2003
2003
Purpose. A majority of ocular viral diseases are caused by herpes group of viruses. Such infections, especially atypical herpetic… 
Highly Cited
2003
Highly Cited
2003
The availability of tetrameric complexes of HLA class I molecules folded with immunodominant peptides makes it possible to… 
Highly Cited
2000
Highly Cited
2000
Radioiodide concentrating activity in the thyroid, mediated by human Na+/I− symporter (hNIS), provides a mechanism for effective…